MedTrace Logo

Serological Study of the Exposure of Personnel to COVID-19

NCT04422977 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 957

Last updated 2024-04-04

No results posted yet for this study

Summary

A seroconversion test for SARS-Cov-2 will be offered to all the employees of a care institution, which has treated 240 patients hospitalized for COVID disease between 28/02 and 30/04/2020. The seroconversion test will be with a questionnaire to determine:

* whether the subject has shown signs of infection in the last 3 recent months
* if the subject has been in contact with COVID-diagnosed subjects (RT-PCR diagnosis or scanner) outside of the activity or within the professional activity (patient or colleague)
* Working conditions during the period
* The level of knowledge and respect of the barrier measures practices.
* Respect for distance during meals professional. Overall seroprevalence and stratified seroprevalence by care and administrative areas will be determined.

Conditions

  • Sars-CoV2

Interventions

DIAGNOSTIC_TEST

Sars-Cov-2 serology

Measurement of overall seroprevalence of SARS-Cov-2 in an hospital staff

Sponsors & Collaborators

  • Centre Hospitalier Saint Joseph Saint Luc de Lyon

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-08
Primary Completion
2020-07-10
Completion
2020-07-10

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04422977 on ClinicalTrials.gov